FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

76170011000036108: Optiray-350 Ultraject (ioversol 741 mg / 1 mL) injection, 50 mL syringe (trade product unit of use)

Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3073881000168119 Optiray-350 Ultraject (ioversol 741 mg / 1 mL) injection, 50 mL syringe (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3073891000168116 Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe has manufactured dose form injection true Inferred relationship Some
Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe Is a trade product unit of use true Inferred relationship Some
Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe Is a Optiray-350 Ultraject true Inferred relationship Some
Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe Is a ioversol 741 mg (iodine 350 mg)/mL injection, 50 mL syringe true Inferred relationship Some
Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe has manufactured dose form injection solution false Inferred relationship Some
Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe has Australian BoSS ioversol true Inferred relationship Some 2081810490
Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe has unit of use syringe true Inferred relationship Some 2081810491
Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe has intended active ingredient ioversol true Inferred relationship Some 2081810490
Inbound Relationships Type Active Source Characteristic Refinability Group
Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 10 x 50 mL syringes has TPUU True Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe Inferred relationship Some 1
Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe has TPUU True Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe Inferred relationship Some 1
Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 10 x 50 mL syringes has TPUU True Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe Inferred relationship Some 1
Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe has TPUU True Optiray-350 Ultraject 741 mg (iodine 350 mg)/mL injection, 50 mL syringe Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start